Financial Assumptions
Assumptions
Projected revenue and margin assumptions across the TongueVǎge™ product ecosystem.
Device
Business Model
Revenue Streams
In addition to sales of the TongueVǎge™ device, additional revenue streams will include but are not limited to:
Go-to-Market
Marketing Channels
Projections
Scenario: 100,000 Active Users
Projections presented herein are best-guess estimates based on the current healthcare market and industry outlook, current products and devices for oral hygiene. There is no expressed or implied guarantee of success; and, there is a risk of financial loss.
Exit Strategy
Estimated Enterprise Value
Consumer-health companies commonly sell for approximately 3–5× revenue or 8–12× EBITDA.
Low
$35 Million
Mid
$50 Million
High
$70 Million
TongueVǎge™ seeks to create the powered tongue biofilm removal category. That comparison is likely to resonate with Waterpik, SmartMouth, Oral-B, and Philips Sonicare — because the business model of device plus recurring consumables is very similar.
All figures represent management projections based on comparable oral care device categories and current market pricing. Actual results may vary.